Barclays’s Molecular Templates, Inc. MTEM Stock Holding History

Barclays’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-77	Closed	-$51K	–	6735
2015 Q3	$51K	Buy	+77	New	+$54.8K	﹤0.01%	5014
2015 Q2	–	Sell	-25	Closed	-$16K	–	7269
2015 Q1	$16K	Buy	25 +23	+1,150%	+$15.1K	﹤0.01%	5962
2014 Q4	$1K	Sell	2 -32	-94%	-$16K	﹤0.01%	7195
2014 Q3	$17K	Buy	34 +31	+1,033%	+$21.4K	﹤0.01%	6600
2014 Q2	$2K	Sell	3 -1,216	-100%	-$806K	﹤0.01%	7429
2014 Q1	$804K	Buy	1,219 +1,198	+5,705%	+$973K	﹤0.01%	3483
2013 Q4	$14K	Sell	21 -41	-66%	-$30.9K	﹤0.01%	6882
2013 Q3	$41K	Sell	62 -47	-43%	-$38.6K	﹤0.01%	6175
2013 Q2	$95K	Buy	+109	New	+$92.2K	﹤0.01%	5833

Barclays's MTEM Position: Q1 2025 in Review

Barclays sold out of Molecular Templates, Inc. (MTEM) in Q1 2025, closing a stake of 102 shares — an estimated $4 sold.

Barclays first reported a position in MTEM in Q2 2013 and held it in 36 quarters. The position peaked at $291K in Q1 2021. 0 funds tracked by Wall St. Rank hold MTEM as of Q1 2025.

Barclays reported no remaining Molecular Templates, Inc. position as of Q1 2025 after selling out during the quarter.
Barclays sold 102 Molecular Templates, Inc. shares in Q1 2025, an estimated $4.
Barclays first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 36 quarters.
Barclays's Molecular Templates, Inc. position peaked at $291K in Q1 2021.
0 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.